Skip to main content

Sage Therapeutics to Report Third Quarter 2023 Financial Results on Tuesday, November 7, 2023

Sage Therapeutics, Inc. (Nasdaq: SAGE), a biopharmaceutical company leading the way to create a world with better brain health, announced today that it will host a live webcast on Tuesday, November 7, 2023 at 8:00 a.m. ET to review third quarter 2023 financial results and discuss recent business updates.

The webcast can be accessed on the Investor page of Sage’s website at investor.sagerx.com. A replay of the webcast will be available following the completion of the event and will be archived for up to 30 days.

About Sage Therapeutics

Sage Therapeutics is a biopharmaceutical company fearlessly leading the way to create a world with better brain health. Our mission is to pioneer solutions to deliver life-changing brain health medicines, so every person can thrive. For more information, please visit www.sagerx.com.

Contacts

Recent Quotes

View More
Symbol Price Change (%)
AMZN  210.32
-12.37 (-5.55%)
AAPL  278.03
+2.12 (0.77%)
AMD  208.44
+15.94 (8.28%)
BAC  56.53
+1.59 (2.89%)
GOOG  323.10
-8.23 (-2.48%)
META  661.46
-8.75 (-1.31%)
MSFT  400.78
+7.11 (1.81%)
NVDA  185.41
+13.53 (7.87%)
ORCL  142.82
+6.34 (4.65%)
TSLA  411.11
+13.90 (3.50%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.